JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
JELD-WEN Holding
JELD
$155M
| $1.61M | ﹤0.01% |
127,315
+29,789
| +31% | +$368K |
2017 Q1
24 quarters
|
|
3527
PUT
Elevance Health
ELV
$88.2B
| $1.61M | ﹤0.01% |
3,500
| – | – |
2022 Q2
3 quarters
|
|
3528
Star Bulk Carriers
SBLK
$3.46B
| $1.6M | ﹤0.01% |
+75,970
| New | +$1.66M |
2023 Q1
0 quarters
|
|
3529
CALL
Humana
HUM
$48.7B
| $1.6M | ﹤0.01% |
3,300
+2,400
| +267% | +$1.19M |
2021 Q2
7 quarters
|
|
|
CTO
3530
CTO Realty Growth
CTO
$767M
| $1.6M | ﹤0.01% |
92,752
-71,480
| -44% | -$1.29M |
2017 Q4
21 quarters
|
|
3531
CALL
Roblox
RBLX
$32.9B
| $1.6M | ﹤0.01% |
35,600
+15,300
| +75% | +$585K |
2022 Q1
4 quarters
|
|
3532
Joby Aviation
JOBY
$5.64B
| $1.6M | ﹤0.01% |
368,622
+73,904
| +25% | +$306K |
2021 Q3
6 quarters
|
|
|
CLSA
3533
DELISTED
Cabana Target Leading Sector Aggressive ETF
CLSA
| $1.6M | ﹤0.01% |
+85,497
| New | +$1.6M |
2023 Q1
0 quarters
|
|
3534
Mid Penn Bancorp
MPB
$911M
| $1.59M | ﹤0.01% |
62,183
-299
| -0.5% | -$8.85K |
2018 Q2
19 quarters
|
|
3535
TriMas Corp
TRS
$1.37B
| $1.59M | ﹤0.01% |
57,135
+11,090
| +24% | +$325K |
2013 Q2
39 quarters
|
|
|
CCLP
3536
DELISTED
CSI Compressco LP
CCLP
| $1.59M | ﹤0.01% |
1,291,796
-324,459
| -20% | -$435K |
2022 Q4
1 quarter
|
|
3537
Precision BioSciences
DTIL
$172M
| $1.59M | ﹤0.01% |
70,250
+17,257
| +33% | +$569K |
2019 Q1
16 quarters
|
|
3538
VanEck Vietnam ETF
VNM
$482M
| $1.59M | ﹤0.01% |
+130,255
| New | +$1.58M |
2023 Q1
0 quarters
|
|
3539
N-able
NABL
$843M
| $1.59M | ﹤0.01% |
120,158
-18,597
| -13% | -$206K |
2021 Q3
6 quarters
|
|
3540
CALL
Southern Company
SO
$98.8B
| $1.59M | ﹤0.01% |
22,800
-144,700
| -86% | -$9.74M |
2021 Q2
7 quarters
|
|
3541
Alaunos Therapeutics
TCRT
$1.93M
| $1.59M | ﹤0.01% |
16,783
+6
| +0% | +$571 |
2016 Q4
25 quarters
|
|
3542
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.97B
| $1.58M | ﹤0.01% |
66,473
+61,473
| +1,229% | +$1.45M |
2022 Q2
3 quarters
|
|
3543
PUT
Mercado Libre
MELI
$94.6B
| $1.58M | ﹤0.01% |
1,200
-6,100
| -84% | -$6.94M |
2022 Q3
2 quarters
|
|
3544
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.33B
| $1.58M | ﹤0.01% |
23,786
+10,549
| +80% | +$722K |
2013 Q4
37 quarters
|
|
3545
Bowman Consulting
BWMN
$710M
| $1.57M | ﹤0.01% |
54,838
+54,538
| +18,179% | +$1.43M |
2022 Q4
1 quarter
|
|
3546
Janux Therapeutics
JANX
$1.08B
| $1.57M | ﹤0.01% |
129,657
+25,874
| +25% | +$431K |
2021 Q2
7 quarters
|
|
3547
CALL
TechnipFMC
FTI
$26.5B
| $1.57M | ﹤0.01% |
114,800
+102,800
| +857% | +$1.39M |
2022 Q2
3 quarters
|
|
|
DDL
3548
Dingdong
DDL
$453M
| $1.56M | ﹤0.01% |
405,398
-208,628
| -34% | -$1.01M |
2022 Q2
3 quarters
|
|
3549
Nomad Foods
NOMD
$1.53B
| $1.56M | ﹤0.01% |
83,387
-164,521
| -66% | -$2.9M |
2017 Q2
23 quarters
|
|
3550
CALL
Bath & Body Works
BBWI
$3.6B
| $1.56M | ﹤0.01% |
42,600
-431,800
| -91% | -$18.1M |
2020 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.